Cardlytics (NASDAQ:CDLX) Posts Earnings Results, Beats Estimates By $0.18 EPS

Cardlytics (NASDAQ:CDLXGet Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.18, Briefing.com reports. The company had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The firm’s quarterly revenue was down 15.1% compared to the same quarter last year. During the same period last year, the company posted ($0.26) EPS. Cardlytics updated its Q4 2024 guidance to EPS.

Cardlytics Trading Up 7.4 %

Shares of Cardlytics stock traded up $0.30 during midday trading on Friday, reaching $4.37. The company had a trading volume of 1,752,101 shares, compared to its average volume of 1,242,283. The stock has a fifty day moving average price of $3.69 and a 200 day moving average price of $6.70. Cardlytics has a fifty-two week low of $2.89 and a fifty-two week high of $20.52. The firm has a market cap of $217.80 million, a PE ratio of -1.14 and a beta of 1.61. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.77 and a quick ratio of 1.77.

Analyst Upgrades and Downgrades

CDLX has been the topic of a number of research analyst reports. Evercore ISI started coverage on shares of Cardlytics in a research report on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price on the stock. Northland Capmk lowered Cardlytics from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 16th. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday. Bank of America lowered Cardlytics from a “neutral” rating to an “underperform” rating and cut their price target for the company from $4.00 to $3.50 in a research note on Thursday, August 15th. Finally, Lake Street Capital downgraded Cardlytics from a “buy” rating to a “hold” rating and lowered their price objective for the company from $18.00 to $5.00 in a research note on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and an average target price of $6.92.

View Our Latest Report on CDLX

Insider Buying and Selling at Cardlytics

In other Cardlytics news, CEO Amit Gupta sold 22,607 shares of the stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the completion of the sale, the chief executive officer now directly owns 178,519 shares in the company, valued at approximately $687,298.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Scott A. Hill acquired 40,000 shares of Cardlytics stock in a transaction dated Monday, August 12th. The stock was bought at an average price of $3.58 per share, with a total value of $143,200.00. Following the transaction, the director now directly owns 40,000 shares in the company, valued at $143,200. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Amit Gupta sold 22,607 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now directly owns 178,519 shares in the company, valued at approximately $687,298.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,573 shares of company stock valued at $151,612. 4.40% of the stock is currently owned by company insiders.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.